Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study. Results at 6 and 12 months from a retrospective multi-centric study.

Urotoday
December 16, 2019

Urotoday reporting the multicentric study paper on SoracteLite for the management of BPH.

Read the article here.

Choose language

Please make your choiche

Please select your country/geographic area

The USA version of Elesta website is not yet available.